FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

518 letters match. Newest first.

  1. JB Exchange Inc./Justified Laboratories

    JB Exchange/Justified Laboratories sold unapproved skin tag and mole removal serums online, FDA says.

    High risk
  2. Amazon.com, Inc.

    Amazon distributes unapproved new drugs for mole and skin tag removal, FDA says.

    High risk
  3. FluxxLab LLC

    FDA and FTC warned FluxxLab that its COVID-19 and CBDA/CBD tinctures are unapproved, misbranded drugs marketed with unsupported COVID-19 claims.

    High risk
  4. Custom Research Labs Inc.

    FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.

    High risk
  5. Living Foods LLC

    FDA warned Living Foods LLC that its Bion+Plus, ZeoHeal and Relax Sauna were marketed with unapproved drug and device claims.

    High risk
  6. H2 Beverages, Inc.

    H2 Beverages' hydrogen-infused water beverages are unapproved new drugs and misbranded because of disease and COVID-19 claims.

    High risk
  7. Young Living Essential Oils Corporate

    FDA warned Young Living that consultants' social media and website claims made its essential oil, Ningxia, and CBD products unapproved and misbranded drugs.

    High risk
  8. New Sun Inc.

    New Sun Inc. marketed dietary supplements and CBD products as unapproved drugs with disease-treatment claims, including CBD products for children.

    High risk
  9. Elite Supplement Center LLC and Elite Training Facility LLC

    FDA warned Elite Supplement Center that it sells five SARM products as unapproved new drugs for human use.

    High risk
  10. Thirsty Run LLC / US Royal Honey LLC

    FDA found hidden Viagra and Cialis ingredients in three royal honey products sold online as supplements and drugs.

    High risk
  11. DDI Multinacional S.A. de C.V.

    DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.

    High risk
  12. Herbsens Botanicals

    Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.

    High risk
  13. Klarity Kratom

    Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.

    High risk
  14. Kratom Exchange

    FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.

    High risk
  15. Omni Consumer Products LLC d/b/a YoKratom

    FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.

    High risk
  16. MONQ, LLC

    MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.

    High risk
  17. Monarch PCM, LLC

    Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.

    High risk
  18. Golden Lab LLC

    Golden Lab sold eye and allergy capsules with unapproved drug claims and lacked required supplement manufacturing controls.

    High risk
  19. DLG Naturals, Inc.

    DLG Naturals sold shea butter, seed oils, and Kigelia extract as unapproved new drugs (not FDA-approved) with disease-treatment claims on its website.

    Medium
  20. Hybrid Pharma, LLC

    FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.

    High risk
  21. Aire-Master of America, Inc.

    FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.

    High risk
  22. CAJ Food Products Inc.

    CAJ Food Products marketed Biotta and Juice Performer juices with disease claims, making them unapproved new drugs, FDA says.

    High risk
  23. Hope Botanicals, LLC

    FDA warned Hope Botanicals that its CBD products for animals and humans are unapproved drugs and its raspberry gummies contain an unsafe food additive.

    High risk
  24. Plantacea, LLC dba Kahm

    FDA warned Plantacea, doing business as Kahm, about unapproved CBD drugs for humans and animals and adulterated CBD gummies.

    High risk
  25. Haniel Concepts, Inc. DBA Free State Oils, LLC

    FDA warned Free State Oils over website claims that its CBD products treat disease, including COVID-19, and are unapproved drugs and adulterated foods.

    High risk
  26. Ayuryoga, Inc.

    FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.

    High risk
  27. Santhigram Kerala Ayurvedic Co. of U.S., Inc.

    FDA told Santhigram Kerala Ayurvedic Co. of U.S. that its ayurvedic products are unapproved new drugs sold with disease claims online.

    High risk
  28. Sunny Creek Farm, Inc.

    Sunny Creek Farm sold sprouts from pathogen-positive seed lots and made unapproved disease-treatment claims.

    High risk
  29. Inhousepharmacy.vu

    Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.

    High risk
  30. Ironmag Labs

    FDA warned Ironmag Labs that its CBD Gummies and stimulant supplements are adulterated (illegal because unsafe/missing filings) and unapproved new drugs.

    High risk
  31. Delta 8 Hemp

    FDA warned Delta 8 Hemp over unapproved Delta-8 THC drugs and adulterated gummies sold online.

    High risk
  32. ATLRx, Inc.

    FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.

    High risk
  33. Kingdom Harvest

    Kingdom Harvest marketed CBD and Delta-8 THC products with unapproved drug claims and unsafe food and animal drug uses.

    High risk
  34. BioMD Plus LLC

    FDA warned BioMD Plus LLC that its CBD and Delta-8 THC products are unapproved drugs and its Delta-8 gummies contain an unsafe food additive.

    High risk
  35. M Six Labs, Inc.

    FDA warned M Six Labs over unapproved CBD/Delta-8 THC drugs, illegal CBD/Delta-8 foods, and animal drugs sold online.

    High risk
  36. C R Supplements, LLC

    FDA warned C R Supplements that its mineral supplements were sold as unapproved new drugs and made without required quality controls.

    High risk
  37. MYA International, Inc.

    FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.

    High risk
  38. Rena's Organic

    U.S. Food and Drug Administration (FDA) warned Rena's Organic over unapproved CBD drug claims for tinctures, creams, foods, and pet product.

    High risk
  39. Clinical Resolution Laboratory Inc.

    FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.

    High risk
  40. Kleenhanz, LLC

    FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.

    High risk
  41. AMBI Enterprises LLC

    AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.

    High risk
  42. Genomma Lab USA, Inc.

    Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.

    High risk
  43. www.wellerectile.com

    FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.

    High risk
  44. Generitech Corporation

    FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.

    High risk
  45. NDAL Mfg Inc.

    NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.

    High risk
  46. Honey Feast, Inc.

    Honey Feast, Inc. sold honey products online with disease-treatment claims, making them unapproved new drugs and misbranded.

    Low
  47. CBD Social

    FDA and FTC warn CBD Social over website claims that CBD products prevent or treat COVID-19.

    High risk
  48. Functional Remedies, LLC D/B/A Synchronicity Hemp Oil

    FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.

    High risk
  49. Cureganics

    Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.

    High risk
  50. Nature's Highway

    FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.

    High risk